Effects of Stress and Drug-cue Exposure (SCM)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2023

Conditions

Marijuana Abuse

Interventions

DRUG

Yohimbine

Yohimbine (0mg, 20mg, or 40 mg) will be administered at 11:00am on each of the experimental sessions.

Trial Locations (1)

Tolan Park Medical Building, Detroit

All Listed Sponsors

lead

Wayne State University

OTHER

NCT03154567 - Effects of Stress and Drug-cue Exposure (SCM) | Biotech Hunter | Biotech Hunter